Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    March 2017
  1. YU M, Engels MM, Hillebrand A, van Straaten EC, et al
    Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.
    Brain. 2017 Mar 16. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  2. BANERJEE G, Kim HJ, Fox Z, Jager HR, et al
    MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Brain. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. REEVES S, McLachlan E, Bertrand J, Antonio FD, et al
    Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
    Brain. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. HUSAIN M
    Alzheimer's disease: time to focus on the brain, not just molecules.
    Brain. 2017;140.
    PubMed     Text format    


    January 2017
  5. PASSAMONTI L, Vazquez Rodriguez P, Hong YT, Allinson KS, et al
    18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Brain. 2017 Jan 24. pii: aww340. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. FAN Z, Brooks DJ, Okello A, Edison P, et al
    An early and late peak in microglial activation in Alzheimer's disease trajectory.
    Brain. 2017 Jan 24. pii: aww349. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. HAYES JP, Logue MW, Sadeh N, Spielberg JM, et al
    Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
    Brain. 2017 Jan 11. pii: aww344. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  8. ALVES S, Churlaud G, Audrain M, Michaelsen-Preusse K, et al
    Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
    Brain. 2016 Dec 20. pii: aww330. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. DONG A, Toledo JB, Honnorat N, Doshi J, et al
    Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
    Brain. 2016 Dec 20. pii: aww319. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  10. ROGAEVA E, Schmitt-Ulms G
    Does BDNF Val66Met contribute to preclinical Alzheimer's disease?
    Brain. 2016;139.
    PubMed     Text format    


    September 2016
  11. JAMES BD, Wilson RS, Boyle PA, Trojanowski JQ, et al
    TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    Brain. 2016.
    PubMed     Text format     Abstract available


  12. O'SULLIVAN MJ, Vann SD
    Amyloid imaging and Alzheimer's disease: the unsolved cases.
    Brain. 2016;139.
    PubMed     Text format    


  13. COHEN AD
    Distinct pathways for cognitive decline in the presence of Alzheimer's disease pathology or cerebrovascular disease.
    Brain. 2016;139.
    PubMed     Text format    


    August 2016
  14. TIWARI SS, Mizuno K, Ghosh A, Aziz W, et al
    Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.
    Brain. 2016.
    PubMed     Text format     Abstract available


  15. LIM YY, Hassenstab J, Cruchaga C, Goate A, et al
    BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  16. HANSSON O, Gouras G
    Brain activity and Alzheimer's disease: a complex relationship.
    Brain. 2016;139.
    PubMed     Text format    


    July 2016
  17. LEWCZUK P, Kornhuber J
    Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
    Brain. 2016.
    PubMed     Text format    


  18. PALMQVIST S, Mattsson N, Hansson O
    Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
    Brain. 2016.
    PubMed     Text format    


    June 2016
  19. CHETELAT G, Ossenkoppele R, Villemagne VL, Perrotin A, et al
    Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  20. GORDON BA, Friedrichsen K, Brier M, Blazey T, et al
    The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.
    Brain. 2016.
    PubMed     Text format     Abstract available


    May 2016
  21. WOODLING NS, Colas D, Wang Q, Minhas P, et al
    Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.
    Brain. 2016.
    PubMed     Text format     Abstract available


  22. OH H, Madison C, Baker S, Rabinovici G, et al
    Dynamic relationships between age, amyloid-beta deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  23. SARAZIN M, Lagarde J, Bottlaender M
    Distinct tau PET imaging patterns in typical and atypical Alzheimer's disease.
    Brain. 2016;139.
    PubMed     Text format    


  24. THAL DR, Vandenberghe R
    Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2016;139.
    PubMed     Text format    


  25. SCHMAHMANN JD
    Cerebellum in Alzheimer's disease and frontotemporal dementia: not a silent bystander.
    Brain. 2016;139.
    PubMed     Text format    


    April 2016
  26. AGGLETON JP, Pralus A, Nelson AJ, Hornberger M, et al
    Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit.
    Brain. 2016.
    PubMed     Text format     Abstract available


  27. RABINOVICI GD
    Amyloid biomarkers: pushing the limits of early detection.
    Brain. 2016;139.
    PubMed     Text format    


  28. HARPER L, Fumagalli GG, Barkhof F, Scheltens P, et al
    MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.
    Brain. 2016;139.
    PubMed     Text format     Abstract available


  29. HABES M, Erus G, Toledo JB, Zhang T, et al
    White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Brain. 2016;139.
    PubMed     Text format     Abstract available


    March 2016
  30. HAMELIN L, Lagarde J, Dorothee G, Leroy C, et al
    Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
    Brain. 2016.
    PubMed     Text format     Abstract available


  31. OSSENKOPPELE R, Schonhaut DR, Scholl M, Lockhart SN, et al
    Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  32. PALMQVIST S, Mattsson N, Hansson O
    Cerebrospinal fluid analysis detects cerebral amyloid-beta accumulation earlier than positron emission tomography.
    Brain. 2016.
    PubMed     Text format     Abstract available


  33. DURAN-ANIOTZ C, Cornejo VH, Hetz C
    Targeting endoplasmic reticulum acetylation to restore proteostasis in Alzheimer's disease.
    Brain. 2016;139.
    PubMed     Text format    


  34. SCHOTT JM, Fox NC
    Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know?
    Brain. 2016;139.
    PubMed     Text format    


  35. DUZEL E, van Praag H, Sendtner M
    Can physical exercise in old age improve memory and hippocampal function?
    Brain. 2016;139.
    PubMed     Text format     Abstract available


    February 2016
  36. SPANGENBERG EE, Lee RJ, Najafi AR, Rice RA, et al
    Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-beta pathology.
    Brain. 2016.
    PubMed     Text format     Abstract available


  37. GUO CC, Tan R, Hodges JR, Hu X, et al
    Network-selective vulnerability of the human cerebellum to Alzheimer's disease and frontotemporal dementia.
    Brain. 2016.
    PubMed     Text format     Abstract available


  38. DANSOKHO C, Ait Ahmed D, Aid S, Toly-Ndour C, et al
    Regulatory T cells delay disease progression in Alzheimer-like pathology.
    Brain. 2016.
    PubMed     Text format     Abstract available


    January 2016
  39. RODRIGUEZ-VIEITEZ E, Saint-Aubert L, Carter SF, Almkvist O, et al
    Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  40. ZHU QB, Unmehopa U, Bossers K, Hu YT, et al
    MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  41. PENG Y, Kim MJ, Hullinger R, O'Riordan KJ, et al
    Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse.
    Brain. 2016.
    PubMed     Text format     Abstract available


  42. OLMOS-ALONSO A, Schetters ST, Sri S, Askew K, et al
    Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Brain. 2016.
    PubMed     Text format     Abstract available


  43. JAGUST W
    Is amyloid-beta harmful to the brain? Insights from human imaging studies.
    Brain. 2016;139.
    PubMed     Text format     Abstract available


    December 2015
  44. HAAS LT, Salazar SV, Kostylev MA, Um JW, et al
    Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  45. KIMBROUGH IF, Robel S, Roberson ED, Sontheimer H, et al
    Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  46. SORG C, Grothe MJ
    The complex link between amyloid and neuronal dysfunction in Alzheimer's disease.
    Brain. 2015;138.
    PubMed     Text format    


    November 2015
  47. JONES DT, Knopman DS, Gunter JL, Graff-Radford J, et al
    Cascading network failure across the Alzheimer's disease spectrum.
    Brain. 2015.
    PubMed     Text format     Abstract available


  48. RYAN NS, Rossor MN, Fox NC
    Alzheimer's disease in the 100 years since Alzheimer's death.
    Brain. 2015.
    PubMed     Text format    


  49. FLETCHER PD, Downey LE, Golden HL, Clark CN, et al
    Pain and temperature processing in dementia: a clinical and neuroanatomical analysis.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    October 2015
  50. FAN Z, Okello AA, Brooks DJ, Edison P, et al
    Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  51. ESCOTT-PRICE V, Sims R, Bannister C, Harold D, et al
    Common polygenic variation enhances risk prediction for Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  52. MAYA Y, Okumura Y, Kobayashi R, Onishi T, et al
    Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-beta.
    Brain. 2015.
    PubMed     Text format     Abstract available


  53. KULLMANN DM
    Editorial.
    Brain. 2015;138.
    PubMed     Text format    


  54. TAN RH, Kril JJ, Fatima M, McGeachie A, et al
    TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    September 2015
  55. PORTELIUS E, Zetterberg H, Skillback T, Tornqvist U, et al
    Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


    August 2015
  56. BRAAK H, Del Tredici K
    The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  57. FRINGS L, Hellwig S, Spehl TS, Bormann T, et al
    Asymmetries of amyloid-beta burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  58. RAMANAN VK, Risacher SL, Nho K, Kim S, et al
    GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.
    Brain. 2015.
    PubMed     Text format     Abstract available


  59. CLARK CN, Warren JD
    Music, memory and mechanisms in Alzheimer's disease.
    Brain. 2015;138.
    PubMed     Text format    


    July 2015
  60. TOLEDO JB, Zetterberg H, van Harten AC, Glodzik L, et al
    Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
    Brain. 2015.
    PubMed     Text format     Abstract available


  61. DJELTI F, Braudeau J, Hudry E, Dhenain M, et al
    CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  62. OSSENKOPPELE R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, et al
    The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Brain. 2015.
    PubMed     Text format     Abstract available


  63. ANTONIADES CA, Kennard C
    Oculomotor abnormalities in posterior cortical atrophy: are they different from those in Alzheimer's disease after all?
    Brain. 2015;138.
    PubMed     Text format    


  64. CUMMINGS DM, Liu W, Portelius E, Bayram S, et al
    First effects of rising amyloid-beta in transgenic mouse brain: synaptic transmission and gene expression.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  65. SHAKESPEARE TJ, Kaski D, Yong KX, Paterson RW, et al
    Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    June 2015
  66. KORONYO Y, Salumbides BC, Sheyn J, Pelissier L, et al
    Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  67. JACOBSEN JH, Stelzer J, Fritz TH, Chetelat G, et al
    Why musical memory can be preserved in advanced Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  68. DICKSON DW, Murray ME
    Intraneuronal amyloid-beta accumulation in basal forebrain cholinergic neurons: a marker of vulnerability, yet inversely related to neurodegeneration.
    Brain. 2015;138.
    PubMed     Text format    


    May 2015
  69. KROHN M, Bracke A, Avchalumov Y, Schumacher T, et al
    Accumulation of murine amyloid-beta mimics early Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  70. WANG DB, Kinoshita Y, Kinoshita C, Uo T, et al
    Loss of endophilin-B1 exacerbates Alzheimer's disease pathology.
    Brain. 2015.
    PubMed     Text format     Abstract available


  71. VILLENEUVE S, Rabinovici GD, Cohn-Sheehy BI, Madison C, et al
    Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
    Brain. 2015.
    PubMed     Text format     Abstract available


  72. SCHOTT JM, Petersen RC
    New criteria for Alzheimer's disease: which, when and why?
    Brain. 2015;138.
    PubMed     Text format    


  73. SHULTZ SR, Wright DK, Zheng P, Stuchbery R, et al
    Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    April 2015
  74. SEPULVEDA-DIAZ JE, Alavi Naini SM, Huynh MB, Ouidja MO, et al
    HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Brain. 2015.
    PubMed     Text format     Abstract available


  75. AIZENSTEIN HJ, Klunk WE
    Where is hippocampal activity in the cascade of Alzheimer's disease biomarkers?
    Brain. 2015;138.
    PubMed     Text format    


    March 2015
  76. MURRAY ME, Lowe VJ, Graff-Radford NR, Liesinger AM, et al
    Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Brain. 2015.
    PubMed     Text format     Abstract available


  77. PARRA MA, Saarimaki H, Bastin ME, Londono AC, et al
    Memory binding and white matter integrity in familial Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  78. BAKER-NIGH A, Vahedi S, Davis EG, Weintraub S, et al
    Neuronal amyloid-beta accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  79. FAGAN AM
    What does it mean to be 'amyloid-positive'?
    Brain. 2015;138.
    PubMed     Text format    


  80. VEMURI P, Lesnick TG, Przybelski SA, Knopman DS, et al
    Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    February 2015
  81. VOS SJ, Verhey F, Frolich L, Kornhuber J, et al
    Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Brain. 2015.
    PubMed     Text format     Abstract available


  82. THOMAS T, Miners S, Love S
    Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia.
    Brain. 2015.
    PubMed     Text format     Abstract available


  83. LAI AY, Dorr A, Thomason LA, Koletar MM, et al
    Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  84. RINGMAN JM, Liang LJ, Zhou Y, Vangala S, et al
    Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.
    Brain. 2015.
    PubMed     Text format     Abstract available


  85. COHEN ML, Kim C, Haldiman T, ElHag M, et al
    Rapidly progressive Alzheimer's disease features distinct structures of amyloid-beta
    Brain. 2015.
    PubMed     Text format     Abstract available


  86. LAGARDE J, Valabregue R, Corvol JC, Garcin B, et al
    Why do patients with neurodegenerative frontal syndrome fail to answer: 'In what way are an orange and a banana alike?'.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    January 2015
  87. FRENKEL D
    A new TRAIL in Alzheimer's disease therapy.
    Brain. 2015;138.
    PubMed     Text format    


    December 2014
  88. MATTSSON N, Insel PS, Donohue M, Landau S, et al
    Independent information from cerebrospinal fluid amyloid-beta and florbetapir imaging in Alzheimer's disease.
    Brain. 2014.
    PubMed     Text format     Abstract available


  89. GJERLOFF T, Fedorova T, Knudsen K, Munk OL, et al
    Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
    Brain. 2014.
    PubMed     Text format     Abstract available


  90. RICHETIN K, Leclerc C, Toni N, Gallopin T, et al
    Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer's disease.
    Brain. 2014.
    PubMed     Text format     Abstract available


  91. CANTARELLA G, Di Benedetto G, Puzzo D, Privitera L, et al
    Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Brain. 2014.
    PubMed     Text format     Abstract available


  92. GOLDEN HL, Nicholas JM, Yong KX, Downey LE, et al
    Auditory spatial processing in Alzheimer's disease.
    Brain. 2014.
    PubMed     Text format     Abstract available


  93. LIM HK, Nebes R, Snitz B, Cohen A, et al
    Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


    June 2014
  94. FOSTER V, Oakley AE, Slade JY, Hall R, et al
    Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias.
    Brain. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: